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Abstract
Background Cardiac defects can be the presenting
symptom in patients with mutations in the X-linked gene
FLNA. Dysfunction of this gene is associated with cardiac
abnormalities, especially in the left ventricular outflow
tract, but can also cause a congenital malformation of the
cerebral cortex. We noticed that some patients diagnosed at
the neurogenetics clinic had first presented to a cardiolo-
gist, suggesting that earlier recognition may be possible if
the diagnosis is suspected.
Methods and results From the Erasmus MC cerebral
malformations database 24 patients were identified with
cerebral bilateral periventricular nodular heterotopia
(PNH) without other cerebral cortical malformations. In six
of these patients, a pathogenic mutation in FLNA was
present. In five a cardiac defect was also found in the
outflow tract. Four had presented to a cardiologist before
the cerebral abnormalities were diagnosed.
Conclusions The cardiological phenotype typically con-
sists of aortic or mitral regurgitation, coarctation of the
aorta or other left-sided cardiac malformations. Most
patients in this category will not have a FLNA mutation,
but the presence of neurological complaints, hyperlaxity of
the skin or joints and/or a family history with similar car-
diac or neurological problems in a possibly X-linked pat-
tern may alert the clinician to the possibility of a FLNA
mutation.
Keywords Filamin A  Outflow tract  Mitral valve 
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Introduction
Cardiac defects in adults are usually sporadic and rarely
considered to be part of a hereditary syndrome. The pres-
ence of other congenital malformations or a positive family
history should alert the clinician to the possibility of an
underlying, possibly genetic cause [1, 2]. Combined neu-
rological and cardiac disease is well recognized in neuro-
muscular disorders [3]. However, a cardiac defect can also
be the presenting symptom in patients with a congenital
malformation of the cerebral cortex due to mutations in the
X-linked gene FLNA (OMIM 300017). Dysfunction of this
gene leads to abnormalities in outflow tract development,
often manifesting as a mitral or aortic valve insufficiency
and a cerebral migration disorder, characterized by clusters
of grey matter along the ventricles consisting of neurons
that failed to migrate to the cortex during prenatal devel-
opment [4]. Some mutations in FLNA can lead to cranio-
facial and skeletal abnormalities, including otopalatodigital
(OPD) syndrome types 1 (OMIM 311300) and 2
(OMIM 304120), Melnick-Needles syndrome (MNS, OMIM
309350) and frontometaphyseal dysplasia (FMD, OMIM
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305620). The filamin proteins (FLNA, FLNB and FLNC)
are products of different genes and splice variants. Filamins
stabilize F-actin networks in the cell and link them to cellular
membranes by binding to transmembrane receptors or ion
channels, thereby regulating cell morphology, membrane
integrity and cell locomotion [5]. FLNA and FLNB are
widely expressed, while FLNC is restricted to the striated
muscle. Mutations in FLNC have been associated with
myofibrillar myopathy [6]. FLNA is highly expressed in early
myotubes, developing myofibrils and migratory neurons.
During myofibril development FLNA is replaced by FLNB
[5]. There seems to be some functional redundancy of both
proteins [7]. Mutations in FLNB have only been described in
skeletal chondrodysplasia, like Larsen syndrome (OMIM
150250), spondylocarpotarsal Dysostosis (OMIM 272460),
atelosteogenesis I and III (OMIM 108720 and 108721) and
boomerang dysplasia (OMIM 112310). Among these, only
Larsen syndrome occasionally presents with cardiac outflow
tract defects and none with cerebral periventricular nodular
heterotopia (PNH). In this study, we evaluated patients
known with a FLNA mutation for cardiac abnormalities.
Methods
We used our database of patients with malformations of
cortical development to determine how often we see a
combination of cerebral PNH and cardiac abnormalities
due to FLNA mutations, to describe the patient character-
istics and to provide information for the cardiologist as to
when they should be alert to the possibility of an associated
cerebral malformation. FLNA mutations were identified by
direct sequencing of exons and intron exon boundaries
(reference sequence NM_01110556.1).
Results
From our ongoing database of patients with malformations
of cortical development, we identified 24 patients with
bilateral PNH without other cerebral cortical malforma-
tions [8]. In six patients this was due to a pathogenic
mutation in FLNA. Five of these FLNA patients had a
cardiac defect in the outflow tract. Details of these five
patients are found in the table and clinical descriptions
below. Four presented to a cardiologist before the diagnosis
of the cerebral abnormalities was known. In the 18 other
patients with bilateral PNH without other cerebral mal-
formations pathogenic mutations in FLNA were excluded,
and none of these had a cardiac defect as evaluated by a
cardiologist. Patients with other malformations of cortical
development were not all screened by a cardiologist, so the
incidence of cardiac defects in this group cannot be infer-
red from our data.
Clinical reports
Patient 1
The first patient is a boy (patient 1 in Table 1 and Figs. 1,
2), the third child of healthy parents of Somalian descent. A
prenatal ultrasound at 20 weeks showed an unclassified
cardiac abnormality. Pregnancy and term birth (38 weeks)
were uncomplicated. Birth weight was 2,635 g, head cir-
cumference 34 cm (normal). Cardiac ultrasound and cath-
eterization showed a cardiac malformation consisting of a
situs solitus, AVVA concordant, mono-atrium, mitral
atresia, hypoplastic left ventricle, double outlet right ven-
tricle, patent arterial duct, severe hypoplasia of the trans-
verse aortic arch and coarctation of the aorta. Physical
exam showed a normal abdomen, cryptorchidism, a closed
palate and normal facies, apart from minor anomalies of a
preauricular pit on the left side and mildly posteriorly
rotated ears. Neurological evaluation in the neonatal period
showed an alert infant with normal movements, reflexes
and muscle tone. EEG showed no epileptiform discharges.
Brain MRI showed wide cerebral ventricles with bilateral
PNH, a normal cortex, and a bifid septum pellucidum, and
an enlarged retrocerebellar space with normal cerebellum
Table 1 Patient characteristics
Pt Sex Cardiological symptoms Associated
symptoms
Epilepsy Outcome Mutation FLNA
1 M Mono-atrium, mitral atresia, hypoplastic LV,
double outlet RV, aortic coarctation
– – Died age 2 m of heart failure c.5290G[A
2 F Aortic coarctation Hyperlaxity skin
and joints
– Now 2 years old c.220G[A
3 F Severe aortic valve insufficiency – – Died aged 71 years of
subarachnoid hemorrhage
c.3045del5
4 F Mild aortic valve stenosis and regurgitation – ? Now 46 years old c.3582delC
5 F Severe aortic valve regurgitation – – Now 42 years old c.6635delTCAG
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and brainstem. Thorax CT angiogram performed to classify
the cardiac abnormality additionally showed incomplete
fusion of the distal third part of the sternum. The patient
died at the age of 2 months of heart failure. Autopsy was
not allowed and the family was lost to follow-up.
FLNA sequencing of DNA extracted from leukocytes
showed two sequence changes. The missense change
c.5290G[A (p.A1764T) has been reported before in a
woman with PNH and has been described as pathogenic,
although there is no definitive evidence [4]. The second
missense change was found in exon 20 (c.3035C[T)
resulting in a serine to leucine substitution at position 1012
of the protein and has not been reported before in PNH or
in the OPD-spectrum. This is a change in rod 1 (repeat
1–15) before the hinge 1 domain and is predicted to be a
non-tolerated amino acid change in two different computer
models. It is uncertain whether the second missense change
contributes to the phenotype.
Patient 2
During the first pregnancy of a unrelated healthy Dutch
couple prenatal ultrasound and prenatal MRI had shown a
girl with a possibly enlarged heart and mildly enlarged
cerebral ventricles (patient 2 in Table 1 and Fig. 2).
Delivery at term (40.6 wks) was uncomplicated. Birth-
weight was 2,830 g and head circumference 37 cm
(?2 SD). Postnatally, cardiac ultrasound showed a secun-
dum atrial septal defect, coarctation of the aorta and mild
aortic regurgitation. The coarctation was surgically cor-
rected at the age of 16 days by resection and end-to-end
anastomosis. She showed normal to mildly delayed
cognitive development and delayed motor development
with hypotonia and severe hyperlaxity. Facial features
show a broad forehead, prominent orbital ridges, deep set
eyes with down-slant, and a flat midface. She has never
had seizures, and EEG showed no epileptiform dis-
charges. Brain MRI showed bilateral PNH and an
enlarged retrocerebellar cyst (Fig. 1). At the age of
3 months she developed dyspnoea due to congenital
lobar emphysema of the right middle pulmonary lobe
with bronchomalacia. She was successfully treated with a
pulmonary lobectomy.
FLNA sequencing of DNA extracted from leukocytes
showed a missense change c.220G[A in exon 2 (p.G74R).
Family studies showed the mother, not the father, to be
carrier of the same mutation. Cardiological evaluation,
including ultrasound, of the mother was normal. The
mother has hyperlaxity. Brain MRI of the mother showed
bilateral PNH, typical of FLNA mutations. She subse-
quently developed epilepsy at age 27 years. This missense
change was absent in leukocyte DNA of the maternal
grandparents. These have no FLNA related complaints or
symptoms, although brain MRI was not done. Its de novo
occurrence in the family renders it very likely that c.220G[A,
p.G74R is a pathogenic mutation.
Patient 3
A woman with a normal IQ and an otherwise unremarkable
history underwent aortic valve replacement for severe
aortic valve regurgitation at age 40 in 1975 (patient 3 in
Table 1 and Fig. 2). Details on the pathology were lost. At
age 55 she was diagnosed with heart failure and 1 year
later she underwent heart transplantation. Macroscopic
pathology showed a dilated heart and a dilated aortic root.
The left ventricle shows subendocardial fibrosis. At age 60
she was diagnosed with severe venous varicosis of the legs
and at age 70 an infrarenal aortic aneurysm with a 4.7 cm
diameter was found and treated conservatively. She never
had an epileptic seizure and showed no hyperlaxity of
Fig. 1 Neuroimaging
characteristics of a child (patient
2) in A1 and A2, and an adult
(patient 5) in B1 and B2. All are
T1 weighted MRI images. Note
the periventricular nodular
heterotopia (denoted by arrows)
and the enlarged retrocerebellar
space (denoted by a star)
Fig. 2 Pedigrees of the described cases. FLNA mutation carriers in
black, probably affected but deceased persons in gray. Numbers refer
to the described cases
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joints or skin. At age 71 symptoms of mild cognitive
decline prompted a brain CT showing bilateral PNH as
a chance finding. Eight months later she died of a
subarachnoid hemorrhage from a ruptured fusiform
carotid aneurysm. Family history revealed that her
mother had heart problems from a young age and died
from heart failure at age 69, details could not be
recovered. The patient had a healthy twin brother and a
sister and a healthy son. The autopsy showed severe
generalized atherosclerosis with mild dilatation of the
thoracic aorta and an aneurysm of the abdominal aorta
of 7 cm. Brain autopsy showed symmetrical bilateral
PNH, and bilateral fusiform carotid aneurysms with
widespread glomeruloid microvascular changes in the
cerebral cortex [9].
Direct sequence analysis of the FLNA gene in DNA
extracted from leukocytes showed a pathogenic frame shift
mutation c.3045del5 in exon 21.
Patient 4
A 6-year-old girl presented with a cardiac murmur and was
diagnosed with a mild aortic stenosis (9 mm gradient) and
regurgitation with a normal left ventricle diameter that
remained stable over the years (patient 4 in Table 1 and
Fig. 2). She is now 46 years old and has a normal IQ. She
had a first generalized epileptic seizure at age 28. Brain CT
showed bilateral PNH. Dysmorphic evaluation showed no
abnormalities and no hyperlaxity. She has no children and
one healthy brother.
Direct sequence analysis of FLNA in DNA extracted
from leukocytes showed a pathogenic frame shift mutation
c.3582delC in exon 22.
Patient 5
A girl presented shortly after birth with cyanosis during
feeding and was diagnosed with a ventricular septal
defect and aortic regurgitation (patient 5 in Table 1 and
Fig. 2). At age 24 the ventricular septal defect was sur-
gically corrected and she received an aortic bioprosthesis.
At age 36 years she underwent a Bentall procedure. At
age 40, she presented to a neurologist because of a
complicated migraine attack with aphasia. A brain MRI
showed bilateral PNH and an enlarged retrocerebellar
space (Fig. 1). Family history revealed that her mother
died suddenly at age 57 from a rupture of the aorta. The
patient has one sister with mild aortic regurgitation, she
has been invited for counseling. The patient has a healthy
son.
Direct sequence analysis of FLNA in DNA extracted
from leukocytes showed a pathogenic mutation frame shift
mutation c.6635delTCAG in exon 41.
Discussion
Five out of six patients with a pathogenic mutation in
FLNA from our database show a combination of cardiac
disease and bilateral cerebral PNH. Four patients presented
to a cardiologist before or at the time of their neurological
workup. Neurological signs were absent or mild at that
time and the diagnosis of bilateral PNH was made later due
to epileptic seizures (case 4), hypotonia (case 2) or during
the workup of non-related complaints. This suggests that
the cardiologist had the first opportunity to recognize these
patients. Recently also X-linked mitral valvular dystrophy
without neurological signs or symptoms of epilepsy was
found to be caused by mutations in FLNA, however, brain
imaging was not reported [10]. The cardiological pheno-
type is not always this specific. FLNA knock out mice
show midline skeletal defects and early male lethality due
to cardiac malformations in atrioventricular septal and
outflow tract development [11]. Human patients also show
abnormalities in the outflow tract ranging from patent
ductus arteriosus, mitral or aortic valvular abnormalities to
coarctation of the aorta, and ascending aorta aneurysm [12–
14]. Cerebral PNH in FLNA patients is caused by impaired
migration of later born neurons due to disrupted cell
adhesion and abnormal ventricular ependymal function
[15]. This shows that pathways involved in cell adhesion
can both affect the neuro-epithelium and vascular devel-
opment. Apart from cerebral and cardiovascular develop-
mental defects FLNA mutations can also cause connective
tissue abnormalities, and autopsy studies show abnormal
glomeruloid microvascular proliferations in the brain [9,
15]. A combination of PNH and Ehlers-Danlos syndrome
with joint hyperlaxity and aorta aneurysms caused by a
mutation in FLNA has been described in females [16].
Neurological phenotypes associated with PNH are diverse
and range from epilepsy and normal development to
patients with multiple congenital anomalies and mental
retardation. In males mutations are often prenatal lethal.
Less severe mutations with residual filamin A function are
found in males with PNH. One male patient has been
described with PNH and a lethal complex cardiac malfor-
mation, including atrial and ventricular septal defect and
persistent left superior caval vein [12]. Interestingly, gain
of function mutations of FLNA are associated with syn-
dromes with craniofacial and skeletal abnormalities,
including otopalatodigital syndrome types 1 and 2, Melnick-
Needles syndrome (MNS) and frontometaphyseal dysplasia
[17]. In these syndromes several male patients have been
described with heart defects, cryptorchidism and umbilical
hernia, but no PNH [17]. The combination of mitral and/or
aortic regurgitation and skeletal abnormalities with hyper-
laxity is also found in autosomal dominant Marfan syndrome
(OMIM 154700), in the allelic Shprintzen-Goldberg
48 Clin Res Cardiol (2011) 100:45–50
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syndrome (OMIM 182212) and in Loeys-Dietz syndrome
type 1A and B (OMIM 609192 and 610168). Some neuro-
muscular abnormalities are described in these patients, but no
cerebral cortical developmental abnormalities.
Although we did not find any cases, cardiac defects are
reported to be associated with some other cerebral PNH
phenotypes. Patients with Williams syndrome, caused by a
microdeletion of chromosome 7q11.22-23, have distinctive
facial dysmorphias, ‘elfin face’, and often cardiac defects,
such as supravalvular aortic stenosis, mitral or pulmonary
valve abnormalities, and atrial or ventricular septum defect.
One case has been described with associated PNH [18]. In
chromosome 6q terminal deletion syndrome, brain MRI
commonly shows hypoplasia of the corpus callosum, and a
few patients have been described with associated PNH
[19]. About half of 6q terminal deletion patients are
reported to have cardiac abnormalities, primarily ventric-
ular or atrial septum defect. Distal duplications of chro-
mosome 5p have been associated with PNH in two patients,
one of which also had atrial septum defect and mitral and
tricuspid valve prolapse [20]. Genetic factors related to
similar cardiac malformations without PNH are being
widely investigated, but still only few genes are known to
cause a developmental defect of the atrioventricular septum
and the outflow tract in humans [21–23].
Conclusion
Patients with mutations in FLNA show a cardiological phe-
notype with aortic or mitral regurgitation, coarctation of the
aorta or other left-sided malformations. Although patients with
cardiac defects in this category are numerous and most will not
have a FLNA mutation, the presence of neurological com-
plaints, hyperlaxity of the skin or joints and/or a family history
with similar cardiac or neurological problems in a possibly
X-linked pattern should alert the clinician to the possibility of a
FLNA mutation. Recognition will enable genetic testing and
genetic counseling for patients and their family.
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